Page last updated: 2024-07-31 17:50:33

hirsutine

Description

Cross-References

ID SourceID
PubMed CID3037884
CHEMBL ID327134
MeSH IDM0115565

Synonyms (27)

Synonym
17,18-seco-3-beta-yohimban-16-carboxylic acid, 16,17-didehydro-17-methoxy-, methyl ester, (e)-
hirsutine ,
(e)-16,17-didehydro-17-methoxy-17,18-seco-3-beta-yohimban-16-carboxylic acid methyl ester
corynan-16-carboxylic acid, 16,17-didehydro-17-methoxy-, methyl ester, (3-beta,16e)-
CHEMBL327134 ,
7729-23-9
C16972
methyl (e)-2-[(2s,3r,12br)-3-ethyl-1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a]quinolizin-2-yl]-3-methoxyprop-2-enoate
bdbm50396011
w596of93c7 ,
unii-w596of93c7
corynan-16-carboxylic acid, 16,17-didehydro-17-methoxy-, methyl ester, (3.beta.,16e)-
17,18-seco-3.beta.-yohimban-16-carboxylic acid, 16,17-didehydro-17-methoxy-, methyl ester, (e)-
76376-57-3
indolo(2,3-a)quinolizine-2-acetic acid, 3-ethyl-1,2,3,4,6,7,12,12b-octahydro-.alpha.-(methoxymethylene)-, methyl ester, (.alpha.e,2s,3r,12br)-
AC-34492
dihydrotestosteronebenzoate
Q15614855
HY-N2193
CS-0019501
hirsutine, (3beta,16e)-isomer
MS-25915
indolo(2,3-a)quinolizine-2-acetic acid, 3-ethyl-1,2,3,4,6,7,12,12b-octahydro-alpha-(methoxymethylene)-, methyl ester, (alphae,2s,3r,12br)-
corynan-16-carboxylic acid, 16,17-didehydro-17-methoxy-, methyl ester, (3beta,16e)-
17,18-seco-3beta-yohimban-16-carboxylic acid, 16,17-didehydro-17-methoxy-, methyl ester, (e)-
DTXSID801045724
AKOS040760133

Protein Targets (2)

Inhibition Measurements

ProteinTaxonomyMeasurementAverage (mM)Bioassay(s)
CholinesteraseHomo sapiens (human)IC501.9700AID697830
CholinesteraseEquus caballus (horse)IC504.9700AID697829

Bioassays (6)

Assay IDTitleYearJournalArticle
AID697829Inhibition of horse BChE by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
ISSN: 1464-3391
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID697852Inhibition of electric eel AChE at 2 mg/ml by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
ISSN: 1464-3391
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID697831Inhibition of electric eel AChE by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
ISSN: 1464-3391
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID1599379Antiviral activity against DENV1 infected in human A549 cells after 3 days by focus reduction assay2019European journal of medicinal chemistry, Aug-15, Volume: 176ISSN: 1768-3254Recent update on anti-dengue drug discovery.
AID697830Inhibition of human BChE by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
ISSN: 1464-3391
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID697853Inhibition of horse BChE at 2 mg/ml by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
ISSN: 1464-3391
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.

Research

Studies (38)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (5.26)18.7374
1990's6 (15.79)18.2507
2000's6 (15.79)29.6817
2010's16 (42.11)24.3611
2020's8 (21.05)2.80

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (5.26%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other36 (94.74%)84.16%
SubstanceStudiesClassesRolesFirst YearLast YearAverage AgeRelationship StrengthTrialspre-19901990's2000's2010'spost-2020
quinacrineacridines;
aromatic ether;
organochlorine compound;
tertiary amino compound
antimalarial;
EC 1.8.1.12 (trypanothione-disulfide reductase) inhibitor
201920195.0low000010
4-aminophenolaminophenolallergen;
metabolite
2012201212.0low000010
indoleacetic acidindole-3-acetic acids;
monocarboxylic acid
auxin;
human metabolite;
mouse metabolite;
plant hormone;
plant metabolite
2012201212.0low000010
melatoninacetamides;
tryptamines
anticonvulsant;
central nervous system depressant;
geroprotector;
hormone;
human metabolite;
immunological adjuvant;
mouse metabolite;
radical scavenger
2012201212.0low000010
epibatidinealkaloid2012201212.0low000010
amodiaquineaminoquinoline;
organochlorine compound;
phenols;
secondary amino compound;
tertiary amino compound
anticoronaviral agent;
antimalarial;
drug allergen;
EC 2.1.1.8 (histamine N-methyltransferase) inhibitor;
non-steroidal anti-inflammatory drug;
prodrug
201920195.0low000010
aristolochic acid iaristolochic acids;
aromatic ether;
C-nitro compound;
cyclic acetal;
monocarboxylic acid;
organic heterotetracyclic compound
carcinogenic agent;
metabolite;
mutagen;
nephrotoxin;
toxin
2012201212.0low000010
5-methoxypsoralen5-methoxyfurocoumarin;
organic heterotricyclic compound;
psoralens
hepatoprotective agent;
plant metabolite
2012201212.0low000010
2,3-dimethoxy-5-methyl-6-decyl-1,4-benzoquinone1,4-benzoquinonescofactor2012201212.0low000010
3,3'-diindolylmethaneindolesantineoplastic agent;
P450 inhibitor
2012201212.0low000010
ellipticineindole alkaloid;
organic heterotetracyclic compound;
organonitrogen heterocyclic compound;
polycyclic heteroarene
antineoplastic agent;
plant metabolite
2012201212.0low000010
embelindihydroxy-1,4-benzoquinonesantimicrobial agent;
antineoplastic agent;
hepatitis C protease inhibitor;
plant metabolite
2012201212.0low000010
emodintrihydroxyanthraquinoneantineoplastic agent;
laxative;
plant metabolite;
tyrosine kinase inhibitor
2012201212.0low000010
fluoxetine(trifluoromethyl)benzenes;
aromatic ether;
secondary amino compound
201920195.0low000010
gossypol2012201212.0low000010
hydroxychloroquineaminoquinoline;
organochlorine compound;
primary alcohol;
secondary amino compound;
tertiary amino compound
anticoronaviral agent;
antimalarial;
antirheumatic drug;
dermatologic drug
201920195.0low000010
hypericin2012201212.0low000010
indole-3-carbinolindolyl alcoholantineoplastic agent;
plant metabolite
2012201212.0low000010
nsc 664704indolobenzazepine;
lactam;
organobromine compound
cardioprotective agent;
EC 2.7.11.22 (cyclin-dependent kinase) inhibitor;
EC 2.7.11.26 (tau-protein kinase) inhibitor;
geroprotector
2012201212.0low000010
khellinfuranochromone;
organic heterotricyclic compound;
oxacycle
anti-asthmatic agent;
bronchodilator agent;
cardiovascular drug;
vasodilator agent
2012201212.0low000010
kinetin6-aminopurines;
furans
cytokinin;
geroprotector
2012201212.0low000010
beta-lapachonebenzochromenone;
orthoquinones
anti-inflammatory agent;
antineoplastic agent;
plant metabolite
2012201212.0low000010
lavendustin aaromatic amine2012201212.0low000010
lavendustin b2012201212.0low000010
vitamin k 31,4-naphthoquinones;
vitamin K
angiogenesis inhibitor;
antineoplastic agent;
EC 3.4.22.69 (SARS coronavirus main proteinase) inhibitor;
human urinary metabolite;
nutraceutical
2012201212.0low000010
methoxsalenaromatic ether;
psoralens
antineoplastic agent;
cross-linking reagent;
dermatologic drug;
photosensitizing agent;
plant metabolite
2012201212.0low000010
myristicinorganic molecular entitymetabolite2012201212.0low000010
nalidixic acid1,8-naphthyridine derivative;
monocarboxylic acid;
quinolone antibiotic
antibacterial drug;
antimicrobial agent;
DNA synthesis inhibitor
2012201212.0low000010
niclosamidebenzamides;
C-nitro compound;
monochlorobenzenes;
salicylanilides;
secondary carboxamide
anthelminthic drug;
anticoronaviral agent;
antiparasitic agent;
apoptosis inducer;
molluscicide;
piscicide;
STAT3 inhibitor
201920195.0low000010
6,7-dimethoxy-3-(4-methoxy-6-methyl-7,8-dihydro-5H-[1,3]dioxolo[4,5-g]isoquinolin-5-yl)-3H-isobenzofuran-1-oneisoquinolines2012201212.0medium000010
patulinfuropyran;
gamma-lactone;
lactol
antimicrobial agent;
Aspergillus metabolite;
carcinogenic agent;
mutagen;
mycotoxin;
Penicillium metabolite
2012201212.0low000010
phloretindihydrochalconesantineoplastic agent;
plant metabolite
2012201212.0low000010
prochlorperazineN-alkylpiperazine;
N-methylpiperazine;
organochlorine compound;
phenothiazines
alpha-adrenergic antagonist;
antiemetic;
cholinergic antagonist;
dopamine receptor D2 antagonist;
dopaminergic antagonist;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
first generation antipsychotic
201920195.0low000010
salmeterol xinafoateether;
phenols;
primary alcohol;
secondary alcohol;
secondary amino compound
201920195.0low000010
sanguinarinealkaloid antibiotic;
benzophenanthridine alkaloid;
botanical anti-fungal agent
2012201212.0low000010
streptonigrinpyridines;
quinolone
antimicrobial agent;
antineoplastic agent
2012201212.0low000010
tetrahydropapaverinearomatic ether;
benzylisoquinoline alkaloid;
benzyltetrahydroisoquinoline;
polyether;
secondary amino compound
2012201212.0low000010
theobrominedimethylxanthineadenosine receptor antagonist;
bronchodilator agent;
food component;
human blood serum metabolite;
mouse metabolite;
plant metabolite;
vasodilator agent
2012201212.0low000010
trioxsalenpsoralensdermatologic drug;
photosensitizing agent
2012201212.0low000010
mitomycinmitomycinalkylating agent;
antineoplastic agent
2012201212.0low000010
reserpinealkaloid ester;
methyl ester;
yohimban alkaloid
adrenergic uptake inhibitor;
antihypertensive agent;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
environmental contaminant;
first generation antipsychotic;
plant metabolite;
xenobiotic
2012201212.0low000010
pilocarpine hydrochloridehydrochloride2012201212.0low000010
cantharidincyclic dicarboxylic anhydride;
monoterpenoid
EC 3.1.3.16 (phosphoprotein phosphatase) inhibitor;
herbicide
2012201212.0low000010
physostigminecarbamate ester;
indole alkaloid
antidote to curare poisoning;
EC 3.1.1.8 (cholinesterase) inhibitor;
miotic
2012201212.0low000010
kanamycin akanamycinsbacterial metabolite2012201212.0low000010
veratraminepiperidine alkaloid2012201212.0low000010
phlorhizinaryl beta-D-glucoside;
dihydrochalcones;
monosaccharide derivative
antioxidant;
plant metabolite
2012201212.0low000010
papaverine hydrochloride2012201212.0low000010
colchicinealkaloid;
colchicine
anti-inflammatory agent;
gout suppressant;
mutagen
2012201212.0low000010
yohimbine hydrochloride2012201212.0low000010
cycloheximideantibiotic fungicide;
cyclic ketone;
dicarboximide;
piperidine antibiotic;
piperidones;
secondary alcohol
anticoronaviral agent;
bacterial metabolite;
ferroptosis inhibitor;
neuroprotective agent;
protein synthesis inhibitor
2012201212.0low000010
gliotoxindipeptide;
organic disulfide;
organic heterotetracyclic compound;
pyrazinoindole
antifungal agent;
EC 2.5.1.58 (protein farnesyltransferase) inhibitor;
immunosuppressive agent;
mycotoxin;
proteasome inhibitor
2012201212.0low000010
tubercidinantibiotic antifungal agent;
N-glycosylpyrrolopyrimidine;
ribonucleoside
antimetabolite;
antineoplastic agent;
bacterial metabolite
2012201212.0low000010
veratridinesteroidsodium channel modulator2012201212.0low000010
gibberellic acidC19-gibberellin;
gibberellin monocarboxylic acid;
lactone;
organic heteropentacyclic compound
mouse metabolite;
plant metabolite
2012201212.0low000010
visnaginaromatic ether;
furanochromone;
polyketide
anti-inflammatory agent;
antihypertensive agent;
EC 1.1.1.37 (malate dehydrogenase) inhibitor;
phytotoxin;
plant metabolite;
vasodilator agent
2012201212.0low000010
rotenoneorganic heteropentacyclic compound;
rotenones
antineoplastic agent;
metabolite;
mitochondrial NADH:ubiquinone reductase inhibitor;
phytogenic insecticide;
piscicide;
toxin
2012201212.0low000010
skimmianinealkaloid antibiotic;
organic heterotricyclic compound;
organonitrogen heterocyclic compound;
oxacycle
2012201212.0low000010
syrosingopineyohimban alkaloid2012201212.0low000010
gramineaminoalkylindole;
indole alkaloid;
tertiary amino compound
antibacterial agent;
antiviral agent;
plant metabolite;
serotonergic antagonist
2012201212.0low000010
methylergonovineergoline alkaloid2012201212.0low000010
2,2'-methylenebis(4-methyl-6-tert-butylphenol)diarylmethane2012201212.0low000010
indolebutyric acidindol-3-yl carboxylic acidauxin;
plant hormone;
plant metabolite
2012201212.0low000010
shikimic acidalpha,beta-unsaturated monocarboxylic acid;
cyclohexenecarboxylic acid;
hydroxy monocarboxylic acid
Escherichia coli metabolite;
plant metabolite;
Saccharomyces cerevisiae metabolite
2012201212.0low000010
monocrotalinepyrrolizidine alkaloid2012201212.0low000010
jervinepiperidines2012201212.0low000010
glycyrrhetinic acidcyclic terpene ketone;
hydroxy monocarboxylic acid;
pentacyclic triterpenoid
immunomodulator;
plant metabolite
2012201212.0low000010
boldineaporphine alkaloid2012201212.0low000010
indirubin2012201212.0low000010
plumbaginhydroxy-1,4-naphthoquinone;
phenols
anticoagulant;
antineoplastic agent;
immunological adjuvant;
metabolite
2012201212.0low000010
cepharanthinebisbenzylisoquinoline alkaloid;
isoquinolines
2012201212.0low000010
aloe emodinaromatic primary alcohol;
dihydroxyanthraquinone
antineoplastic agent;
plant metabolite
2012201212.0low000010
ostholbotanical anti-fungal agent;
coumarins
metabolite2012201212.0low000010
cytisinealkaloid;
bridged compound;
lactam;
organic heterotricyclic compound;
secondary amino compound
nicotinic acetylcholine receptor agonist;
phytotoxin;
plant metabolite
2012201212.0low000010
bicucullinebenzylisoquinoline alkaloid;
isoquinoline alkaloid;
isoquinolines
agrochemical;
central nervous system stimulant;
GABA-gated chloride channel antagonist;
GABAA receptor antagonist;
neurotoxin
2012201212.0low000010
kainic aciddicarboxylic acid;
L-proline derivative;
non-proteinogenic L-alpha-amino acid;
pyrrolidinecarboxylic acid
antinematodal drug;
excitatory amino acid agonist
2012201212.0low000010
thymoquinone1,4-benzoquinonesadjuvant;
anti-inflammatory agent;
antidepressant;
antineoplastic agent;
antioxidant;
cardioprotective agent;
plant metabolite
2012201212.0low000010
oleanolic acidhydroxy monocarboxylic acid;
pentacyclic triterpenoid
plant metabolite2012201212.0low000010
podophyllotoxinfuronaphthodioxole;
lignan;
organic heterotetracyclic compound
antimitotic;
antineoplastic agent;
keratolytic drug;
microtubule-destabilising agent;
plant metabolite;
tubulin modulator
2012201212.0low000010
hesperidin3'-hydroxyflavanones;
4'-methoxyflavanones;
dihydroxyflavanone;
disaccharide derivative;
flavanone glycoside;
monomethoxyflavanone;
rutinoside
mutagen2012201212.0low000010
azomycinC-nitro compound;
imidazoles
antitubercular agent2012201212.0low000010
Berberine chloride (TN)organic molecular entity2012201212.0low000010
vincaminealkaloid ester;
hemiaminal;
methyl ester;
organic heteropentacyclic compound;
vinca alkaloid
antihypertensive agent;
metabolite;
vasodilator agent
2012201212.0low000010
muscarine2012201212.0medium000010
ecdysone14alpha-hydroxy steroid;
22-hydroxy steroid;
25-hydroxy steroid;
2beta-hydroxy steroid;
3beta-sterol;
6-oxo steroid;
ecdysteroid
prohormone2012201212.0low000010
n-deacetyl-n-formylcolchicinecyclic ketone2012201212.0medium000010
camptothecindelta-lactone;
pyranoindolizinoquinoline;
quinoline alkaloid;
tertiary alcohol
antineoplastic agent;
EC 5.99.1.2 (DNA topoisomerase) inhibitor;
genotoxin;
plant metabolite
2012201212.0low000010
tetradecanoylphorbol acetateacetate ester;
diester;
phorbol ester;
tertiary alpha-hydroxy ketone;
tetradecanoate ester
antineoplastic agent;
apoptosis inducer;
carcinogenic agent;
mitogen;
plant metabolite;
protein kinase C agonist;
reactive oxygen species generator
2012201212.0low000010
2-bromoergocryptine mesylatemethanesulfonate saltantiparkinson drug2012201212.0medium000010
bromocriptineindole alkaloidantidyskinesia agent;
antiparkinson drug;
dopamine agonist;
hormone antagonist
201920195.0low000010
zingeronemethyl ketone;
monomethoxybenzene;
phenols
anti-inflammatory agent;
antiemetic;
antioxidant;
flavouring agent;
fragrance;
plant metabolite;
radiation protective agent
2012201212.0low000010
paclitaxeltaxane diterpenoid;
tetracyclic diterpenoid
antineoplastic agent;
human metabolite;
metabolite;
microtubule-stabilising agent
2012201212.0low000010
etoposidebeta-D-glucoside;
furonaphthodioxole;
organic heterotetracyclic compound
antineoplastic agent;
DNA synthesis inhibitor
2012201212.0low000010
phorbol 12,13-dibutyratebutyrate ester;
phorbol ester;
tertiary alpha-hydroxy ketone
2012201212.0low000010
cephradinebeta-lactam antibiotic allergen;
cephalosporin
antibacterial drug2012201212.0low000010
quisqualic acidnon-proteinogenic alpha-amino acid2012201212.0low000010
mefloquine[2,8-bis(trifluoromethyl)quinolin-4-yl]-(2-piperidyl)methanolantimalarial201920195.0low000010
colforsinacetate ester;
cyclic ketone;
labdane diterpenoid;
organic heterotricyclic compound;
tertiary alpha-hydroxy ketone;
triol
adenylate cyclase agonist;
anti-HIV agent;
antihypertensive agent;
plant metabolite;
platelet aggregation inhibitor;
protein kinase A agonist
2012201212.0low000010
swainsonineindolizidine alkaloidantineoplastic agent;
EC 3.2.1.114 (mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase) inhibitor;
immunological adjuvant;
plant metabolite
2012201212.0low000010
castanospermineindolizidine alkaloidanti-HIV-1 agent;
anti-inflammatory agent;
EC 3.2.1.* (glycosidase) inhibitor;
metabolite
2012201212.0low000010
daunorubicin hydrochlorideanthracycline2012201212.0low000010
nelfinaviraryl sulfide;
benzamides;
organic heterobicyclic compound;
phenols;
secondary alcohol;
tertiary amino compound
antineoplastic agent;
HIV protease inhibitor
201920195.0low000010
mevastatin2-pyranones;
carboxylic ester;
hexahydronaphthalenes;
polyketide;
statin (naturally occurring)
antifungal agent;
apoptosis inducer;
EC 3.4.24.83 (anthrax lethal factor endopeptidase) inhibitor;
fungal metabolite;
Penicillium metabolite
2012201212.0low000010
ursolic acidhydroxy monocarboxylic acid;
pentacyclic triterpenoid
geroprotector;
plant metabolite
2012201212.0low000010
norharmanbeta-carbolines;
mancude organic heterotricyclic parent
fungal metabolite;
marine metabolite
2012201212.0low000010
betulinic acidhydroxy monocarboxylic acid;
pentacyclic triterpenoid
anti-HIV agent;
anti-inflammatory agent;
antimalarial;
antineoplastic agent;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor;
plant metabolite
201220198.5low000020
baicalindihydroxyflavone;
glucosiduronic acid;
glycosyloxyflavone;
monosaccharide derivative
antiatherosclerotic agent;
antibacterial agent;
anticoronaviral agent;
antineoplastic agent;
antioxidant;
cardioprotective agent;
EC 2.7.7.48 (RNA-directed RNA polymerase) inhibitor;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
ferroptosis inhibitor;
neuroprotective agent;
non-steroidal anti-inflammatory drug;
plant metabolite;
prodrug
201920195.0low000010
epigallocatechin gallateflavans;
gallate ester;
polyphenol
antineoplastic agent;
antioxidant;
apoptosis inducer;
geroprotector;
Hsp90 inhibitor;
neuroprotective agent;
plant metabolite
2012201212.0low000010
baccatin iiiacetate ester;
benzoate ester;
tetracyclic diterpenoid
plant metabolite2012201212.0low000010
taleranolmacrolide2012201212.0low000010
narasinditerpene glycoside2012201212.0high000010
quassintriterpenoid2012201212.0low000010
tomatidine3beta-hydroxy steroid;
azaspiro compound;
oxaspiro compound
2012201212.0low000010
aloxistatinepoxide;
ethyl ester;
L-leucine derivative;
monocarboxylic acid amide
anticoronaviral agent;
cathepsin B inhibitor
2012201212.0low000010
rutecarpinebeta-carbolines2012201212.0low000010
bergenintrihydroxybenzoic acidmetabolite2012201212.0low000010
pinocembrin(2S)-flavan-4-one;
dihydroxyflavanone
antineoplastic agent;
antioxidant;
metabolite;
neuroprotective agent;
vasodilator agent
2012201212.0low000010
isoscopoletinaromatic ether;
hydroxycoumarin
plant metabolite2012201212.0low000010
vinburninealkaloid2012201212.0low000010
epicatechincatechin;
polyphenol
antioxidant2012201212.0low000010
hesperetin3'-hydroxyflavanones;
4'-methoxyflavanones;
monomethoxyflavanone;
trihydroxyflavanone
antineoplastic agent;
antioxidant;
plant metabolite
2012201212.0low000010
magnololbiphenyls2012201212.0low000010
honokiolbiphenyls201220198.5low000020
chelerythrine chloride2012201212.0low000010
betulindiol;
pentacyclic triterpenoid
analgesic;
anti-inflammatory agent;
antineoplastic agent;
antiviral agent;
metabolite
2012201212.0low000010
tetrahydroalstoninemethyl ester;
organic heteropentacyclic compound;
yohimban alkaloid
plant metabolite2012201212.0high000010
hernandezinebisbenzylisoquinoline alkaloid;
isoquinolines
2012201212.0low000010
lycorineindolizidine alkaloidanticoronaviral agent;
antimalarial;
plant metabolite;
protein synthesis inhibitor
201920195.0low000010
picropodophyllinfuronaphthodioxole;
lignan;
organic heterotetracyclic compound
antineoplastic agent;
insulin-like growth factor receptor 1 antagonist;
plant metabolite;
tyrosine kinase inhibitor
2012201212.0low000010
pacein201920195.0low000010
tetrandrinebisbenzylisoquinoline alkaloid;
isoquinolines
2012201212.0low000010
dehydrocostus lactonegamma-lactone;
guaiane sesquiterpenoid;
organic heterotricyclic compound;
sesquiterpene lactone
antimycobacterial drug;
antineoplastic agent;
apoptosis inducer;
cyclooxygenase 2 inhibitor;
metabolite;
trypanocidal drug
2012201212.0low000010
madecassic acidmonocarboxylic acid;
pentacyclic triterpenoid;
tetrol
antioxidant;
plant metabolite
2012201212.0low000010
panaxadioltriterpenoid saponin2012201212.0low000010
tryptanthrinealkaloid antibiotic;
organic heterotetracyclic compound;
organonitrogen heterocyclic compound
2012201212.0low000010
homoeriodictyol3'-methoxyflavanones;
4'-hydroxyflavanones;
monomethoxyflavanone;
trihydroxyflavanone
flavouring agent;
metabolite
2012201212.0low000010
4-hydroxyindolehydroxyindoles;
phenols
2012201212.0low000010
eriocitrin3'-hydroxyflavanones;
4'-hydroxyflavanones;
disaccharide derivative;
flavanone glycoside;
rutinoside;
trihydroxyflavanone
antioxidant2012201212.0low000010
7,8-dihydromethysticin2-pyranones;
aromatic ether
2012201212.0low000010
nicotine3-(1-methylpyrrolidin-2-yl)pyridineanxiolytic drug;
biomarker;
immunomodulator;
mitogen;
neurotoxin;
nicotinic acetylcholine receptor agonist;
peripheral nervous system drug;
phytogenic insecticide;
plant metabolite;
psychotropic drug;
teratogenic agent;
xenobiotic
2012201212.0low000010
cinchonine(8xi)-cinchonan-9-ol;
cinchona alkaloid
metabolite2012201212.0low000010
aucubinorganic molecular entitymetabolite2012201212.0low000010
lupininequinolizidine alkaloid2012201212.0low000010
matrinealkaloid2012201212.0low000010
friedelincyclic terpene ketone;
pentacyclic triterpenoid
anti-inflammatory drug;
antipyretic;
non-narcotic analgesic;
plant metabolite
2012201212.0low000010
catalpolorganic molecular entitymetabolite2012201212.0low000010
quinine hydrochloride2012201212.0high000010
sarsasapogeninsapogenin2012201212.0low000010
corynanthineyohimban alkaloid2012201212.0low000010
prunin protein, prunus(2S)-flavan-4-one;
4'-hydroxyflavanones;
dihydroxyflavanone;
flavanone 7-O-beta-D-glucoside;
monosaccharide derivative
antibacterial agent;
antilipemic drug;
hypoglycemic agent;
metabolite
2012201212.0low000010
podocarpic acidabietane diterpenoid2012201212.0low000010
harmol hydrochloride2012201212.0medium000010
5-Methoxyflavoneether;
flavonoids
2012201212.0medium000010
10-hydroxycamptothecinpyranoindolizinoquinoline2012201212.0low000010
corydalineisoquinoline alkaloid;
isoquinolines
2012201212.0low000010
demissidinealkaloid;
organic heteropolycyclic compound;
steroid
2012201212.0medium000010
cinchonidine(8xi)-cinchonan-9-ol;
cinchona alkaloid
metabolite2012201212.0low000010
propidium iodideorganic iodide salt2012201212.0low000010
tryptolinebeta-carbolines2012201212.0low000010
deguelinaromatic ether;
diether;
organic heteropentacyclic compound;
rotenones
angiogenesis inhibitor;
anti-inflammatory agent;
antineoplastic agent;
antiviral agent;
apoptosis inducer;
EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor;
mitochondrial NADH:ubiquinone reductase inhibitor;
plant metabolite
2012201212.0low000010
catechinhydrategeroprotector2012201212.0medium000010
daidzin7-hydroxyisoflavones 7-O-beta-D-glucoside;
hydroxyisoflavone;
monosaccharide derivative
plant metabolite2012201212.0low000010
cafestolditerpenoid;
furans;
organic heteropentacyclic compound;
primary alcohol;
tertiary alcohol
angiogenesis inhibitor;
anti-inflammatory agent;
antineoplastic agent;
antioxidant;
apoptosis inducer;
hypoglycemic agent;
plant metabolite
2012201212.0low000010
parthenolidegermacranolide2012201212.0low000010
homoorientinflavone C-glycoside;
tetrahydroxyflavone
antineoplastic agent;
radical scavenger
2012201212.0low000010
asiatic acidmonocarboxylic acid;
pentacyclic triterpenoid;
triol
angiogenesis modulating agent;
metabolite
2012201212.0low000010
angustmycin a6-aminopurines2012201212.0low000010
razadyne2012201212.0low000010
phytosphingosineamino alcohol;
sphingoid;
triol
mouse metabolite;
Saccharomyces cerevisiae metabolite
2012201212.0low000010
tetradecanoylphorbol acetate2012201212.0low000010
celastrolmonocarboxylic acid;
pentacyclic triterpenoid
anti-inflammatory drug;
antineoplastic agent;
antioxidant;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor;
Hsp90 inhibitor;
metabolite
2012201212.0low000010
4'-demethylepipodophyllotoxinfuronaphthodioxole;
organic heterotetracyclic compound;
phenols
antineoplastic agent2012201212.0low000010
n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamineleucine derivative2012201212.0low000010
e 64dicarboxylic acid monoamide;
epoxy monocarboxylic acid;
guanidines;
L-leucine derivative;
zwitterion
antimalarial;
antiparasitic agent;
protease inhibitor
2012201212.0low000010
sinensetinpentamethoxyflavoneplant metabolite2012201212.0low000010
harmalol hydrochloride2012201212.0medium000010
ezetimibeazetidines;
beta-lactam;
organofluorine compound
anticholesteremic drug;
antilipemic drug;
antimetabolite
201920195.0low000010
hyoscyaminetropane alkaloid2012201212.0low000010
schizandrin a201220198.5low000020
schizandrin baromatic ether;
cyclic acetal;
organic heterotetracyclic compound;
oxacycle;
tannin
anti-asthmatic agent;
anti-inflammatory agent;
antilipemic drug;
antioxidant;
apoptosis inhibitor;
hepatoprotective agent;
nephroprotective agent;
neuroprotective agent;
plant metabolite
2012201212.0medium000010
cryptotanshinoneabietane diterpenoidanticoronaviral agent2012201212.0low000010
isosakuranetin(2S)-flavan-4-one;
4'-methoxyflavanones;
dihydroxyflavanone;
monomethoxyflavanone
plant metabolite2012201212.0low000010
isovitexinC-glycosyl compound;
trihydroxyflavone
EC 3.2.1.20 (alpha-glucosidase) inhibitor;
metabolite
2012201212.0low000010
sclareollabdane diterpenoidantifungal agent;
antimicrobial agent;
apoptosis inducer;
fragrance;
plant metabolite
2012201212.0low000010
tanshinone ii aabietane diterpenoid2012201212.0low000010
leucodinsesquiterpene lactone2012201212.0low000010
erlotinibaromatic ether;
quinazolines;
secondary amino compound;
terminal acetylenic compound
antineoplastic agent;
epidermal growth factor receptor antagonist;
protein kinase inhibitor
201920195.0low000010
limoninepoxide;
furans;
hexacyclic triterpenoid;
lactone;
limonoid;
organic heterohexacyclic compound
inhibitor;
metabolite;
volatile oil component
2012201212.0low000010
maduramicin2012201212.0low000010
chelidoninealkaloid antibiotic;
alkaloid fundamental parent;
benzophenanthridine alkaloid
2012201212.0low000010
troleandomycinacetate ester;
epoxide;
macrolide antibiotic;
monosaccharide derivative;
polyketide;
semisynthetic derivative
EC 1.14.13.97 (taurochenodeoxycholate 6alpha-hydroxylase) inhibitor;
xenobiotic
2012201212.0low000010
santoninbotanical anti-fungal agent;
santonin
plant metabolite2012201212.0low000010
sitosterol, (3beta)-isomer3beta-hydroxy-Delta(5)-steroid;
3beta-sterol;
C29-steroid;
phytosterols;
stigmastane sterol
anticholesteremic drug;
antioxidant;
mouse metabolite;
plant metabolite;
sterol methyltransferase inhibitor
2012201212.0low000010
vincristine sulfateorganic sulfate saltantineoplastic agent;
geroprotector
2012201212.0low000010
anisomycinmonohydroxypyrrolidine;
organonitrogen heterocyclic antibiotic
anticoronaviral agent;
antimicrobial agent;
antineoplastic agent;
antiparasitic agent;
bacterial metabolite;
DNA synthesis inhibitor;
protein synthesis inhibitor
2012201212.0low000010
lupeolpentacyclic triterpenoid;
secondary alcohol
anti-inflammatory drug;
plant metabolite
201920195.0low000010
acetylstrophanthidinacetate esteranti-arrhythmia drug2012201212.0low000010
Harringtoninealkaloid2012201212.0low000010
acivicinisoxazoles;
non-proteinogenic L-alpha-amino acid;
organochlorine compound
antileishmanial agent;
antimetabolite;
antimicrobial agent;
antineoplastic agent;
EC 2.3.2.2 (gamma-glutamyltransferase) inhibitor;
glutamine antagonist;
metabolite
2012201212.0low000010
ketopinic acid2012201212.0medium000010
wortmanninacetate ester;
cyclic ketone;
delta-lactone;
organic heteropentacyclic compound
anticoronaviral agent;
antineoplastic agent;
autophagy inhibitor;
EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor;
geroprotector;
Penicillium metabolite;
radiosensitizing agent
2012201212.0low000010
gitoxigenin14beta-hydroxy steroid;
16beta-hydroxy steroid;
3beta-hydroxy steroid
2012201212.0low000010
graveolinequinolines2012201212.0low000010
4-oxy-6-(4-oxybezoyloxy)dauc-8,9-en2012201212.0low000010
naringenin(2S)-flavan-4-one;
naringenin
expectorant;
plant metabolite
201220198.5low000020
ouabain11alpha-hydroxy steroid;
14beta-hydroxy steroid;
5beta-hydroxy steroid;
alpha-L-rhamnoside;
cardenolide glycoside;
steroid hormone
anti-arrhythmia drug;
cardiotonic drug;
EC 2.3.3.1 [citrate (Si)-synthase] inhibitor;
EC 3.1.3.41 (4-nitrophenylphosphatase) inhibitor;
EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor;
EC 3.6.3.9 (Na(+)/K(+)-transporting ATPase) inhibitor;
ion transport inhibitor;
plant metabolite
2012201212.0low000010
puromycinpuromycinsantiinfective agent;
antimicrobial agent;
antineoplastic agent;
EC 3.4.11.14 (cytosol alanyl aminopeptidase) inhibitor;
EC 3.4.14.2 (dipeptidyl-peptidase II) inhibitor;
nucleoside antibiotic;
protein synthesis inhibitor
2012201212.0low000010
taxifolintaxifolinmetabolite2012201212.0low000010
mimosine4-pyridones;
amino acid zwitterion;
non-proteinogenic L-alpha-amino acid
EC 1.14.18.1 (tyrosinase) inhibitor;
plant metabolite
2012201212.0low000010
eriodictyol3'-hydroxyflavanones;
tetrahydroxyflavanone
2012201212.0low000010
arbutinbeta-D-glucoside;
monosaccharide derivative
Escherichia coli metabolite;
plant metabolite
2012201212.0low000010
quinidinecinchona alkaloidalpha-adrenergic antagonist;
anti-arrhythmia drug;
antimalarial;
drug allergen;
EC 1.14.13.181 (13-deoxydaunorubicin hydroxylase) inhibitor;
EC 3.6.3.44 (xenobiotic-transporting ATPase) inhibitor;
muscarinic antagonist;
P450 inhibitor;
potassium channel blocker;
sodium channel blocker
2012201212.0low000010
conessinesteroid alkaloid;
tertiary amino compound
antibacterial agent;
antimalarial;
H3-receptor antagonist;
plant metabolite
2012201212.0low000010
griseofulvin1-benzofurans;
antibiotic antifungal drug;
benzofuran antifungal drug;
organochlorine compound;
oxaspiro compound
antibacterial agent;
Penicillium metabolite
2012201212.0low000010
digitoxincardenolide glycosideEC 3.6.3.9 (Na(+)/K(+)-transporting ATPase) inhibitor2012201212.0low000010
hyperforin2012201212.0low000010
deltalineacetate ester;
cyclic acetal;
diterpene alkaloid;
organic polycyclic compound;
tertiary alcohol;
tertiary amino compound
2012201212.0high000010
ingenolcyclic terpene ketone;
tetracyclic diterpenoid
2012201212.0low000010
picrotindiol;
epoxide;
gamma-lactone;
organic heteropentacyclic compound;
picrotoxane sesquiterpenoid;
tertiary alcohol
plant metabolite2012201212.0low000010
picrotoxininepoxide;
gamma-lactone;
organic heteropentacyclic compound;
picrotoxane sesquiterpenoid;
tertiary alcohol
GABA antagonist;
plant metabolite;
serotonergic antagonist
2012201212.0low000010
naringin(2S)-flavan-4-one;
4'-hydroxyflavanones;
dihydroxyflavanone;
disaccharide derivative;
neohesperidoside
anti-inflammatory agent;
antineoplastic agent;
metabolite
2012201212.0low000010
isonaringin(2S)-flavan-4-one;
4'-hydroxyflavanones;
dihydroxyflavanone;
disaccharide derivative;
rutinoside
anti-inflammatory agent;
antioxidant;
metabolite
2012201212.0low000010
ochratoxin aisochromanes;
monocarboxylic acid amide;
N-acyl-L-phenylalanine;
organochlorine compound;
phenylalanine derivative
Aspergillus metabolite;
calcium channel blocker;
carcinogenic agent;
mycotoxin;
nephrotoxin;
Penicillium metabolite;
teratogenic agent
2012201212.0low000010
gingerolbeta-hydroxy ketone;
guaiacols
antineoplastic agent;
plant metabolite
2012201212.0low000010
securinineindolizines2012201212.0low000010
Dubinidineorganic heterotricyclic compound;
organonitrogen heterocyclic compound;
oxacycle
2012201212.0low000010
cyclopaminepiperidinesglioma-associated oncogene inhibitor2012201212.0low000010
1-O-Acetyllycorinealkaloid201920195.0low000010
doxorubicin hydrochlorideanthracycline2012201212.0low000010
vinpocetinealkaloidgeroprotector2012201212.0low000010
dihydroergocristine monomesylatemethanesulfonate saltalpha-adrenergic antagonist;
geroprotector;
vasodilator agent
2012201212.0low000010
tretinoinretinoic acid;
vitamin A
anti-inflammatory agent;
antineoplastic agent;
antioxidant;
AP-1 antagonist;
human metabolite;
keratolytic drug;
retinoic acid receptor agonist;
retinoid X receptor agonist;
signalling molecule
2012201212.0low000010
resveratrolresveratrolantioxidant;
phytoalexin;
plant metabolite;
quorum sensing inhibitor;
radical scavenger
2012201212.0low000010
ferulic acidferulic acidsanti-inflammatory agent;
antioxidant;
apoptosis inhibitor;
cardioprotective agent;
MALDI matrix material;
plant metabolite
2012201212.0low000010
thapsigarginbutyrate ester;
organic heterotricyclic compound;
sesquiterpene lactone
calcium channel blocker;
EC 3.6.3.8 (Ca(2+)-transporting ATPase) inhibitor
2012201212.0low000010
mycophenolic acid2-benzofurans;
gamma-lactone;
monocarboxylic acid;
phenols
anticoronaviral agent;
antimicrobial agent;
antineoplastic agent;
EC 1.1.1.205 (IMP dehydrogenase) inhibitor;
environmental contaminant;
immunosuppressive agent;
mycotoxin;
Penicillium metabolite;
xenobiotic
2012201212.0low000010
alitretinoinretinoic acidantineoplastic agent;
keratolytic drug;
metabolite;
retinoid X receptor agonist
2012201212.0low000010
L-cycloserine4-amino-1,2-oxazolidin-3-oneanti-HIV agent;
anticonvulsant;
EC 2.3.1.50 (serine C-palmitoyltransferase) inhibitor
2012201212.0low000010
12-deoxyphorbol 13-acetatephorbol estermetabolite2012201212.0low000010
dactinomycinactinomycinmutagen2012201212.0low000010
aphidicolintetracyclic diterpenoidantimicrobial agent;
antimitotic;
antineoplastic agent;
antiviral drug;
apoptosis inducer;
Aspergillus metabolite;
DNA synthesis inhibitor;
EC 2.7.7.7 (DNA-directed DNA polymerase) inhibitor;
fungal metabolite
2012201212.0low000010
posaconazolearomatic ether;
conazole antifungal drug;
N-arylpiperazine;
organofluorine compound;
oxolanes;
triazole antifungal drug;
triazoles
trypanocidal drug201920195.0low000010
(+)-usnic acidusnic acid2012201212.0low000010
beta, beta-dimethylacrylshikonin, (+)-isomerhydroxy-1,4-naphthoquinone2012201212.0medium000010
shikoninhydroxy-1,4-naphthoquinone2012201212.0low000010
carbenoxolone201920195.0low000010
rhapontinrhaponticinangiogenesis inhibitor;
anti-allergic agent;
anti-inflammatory agent;
antilipemic drug;
antineoplastic agent;
apoptosis inducer;
EC 2.3.1.85 (fatty acid synthase) inhibitor;
hypoglycemic agent;
neuroprotective agent;
plant metabolite
2012201212.0low000010
citralenal;
monoterpenoid;
polyprenal
plant metabolite;
volatile oil component
201920195.0low000010
piperinebenzodioxoles;
N-acylpiperidine;
piperidine alkaloid;
tertiary carboxamide
food component;
human blood serum metabolite;
NF-kappaB inhibitor;
plant metabolite
2012201212.0low000010
rauwolscinemethyl 17-hydroxy-20xi-yohimban-16-carboxylate2012201212.0low000010
amygdalinamygdalinantineoplastic agent;
apoptosis inducer;
plant metabolite
2012201212.0low000010
lanatoside c201920195.0low000010
hydrastine, (r-(r*,s*))-isomerisoquinolines2012201212.0low000010
vasicine2012201212.0low000010
3,3',4,5'-tetrahydroxystilbenecatechols;
polyphenol;
resorcinols;
stilbenol
antineoplastic agent;
apoptosis inducer;
geroprotector;
hypoglycemic agent;
plant metabolite;
protein kinase inhibitor;
tyrosine kinase inhibitor
2012201212.0low000010
caffeic acidcaffeic acidgeroprotector;
mouse metabolite
2012201212.0low000010
cotinineN-alkylpyrrolidine;
pyridines;
pyrrolidin-2-ones;
pyrrolidine alkaloid
antidepressant;
biomarker;
human xenobiotic metabolite;
plant metabolite
2012201212.0low000010
heliotrinepyrrolizines2012201212.0low000010
sclareolidenaphthofuran2012201212.0low000010
curcuminaromatic ether;
beta-diketone;
diarylheptanoid;
enone;
polyphenol
anti-inflammatory agent;
antifungal agent;
antineoplastic agent;
biological pigment;
contraceptive drug;
dye;
EC 1.1.1.205 (IMP dehydrogenase) inhibitor;
EC 1.1.1.21 (aldehyde reductase) inhibitor;
EC 1.1.1.25 (shikimate dehydrogenase) inhibitor;
EC 1.6.5.2 [NAD(P)H dehydrogenase (quinone)] inhibitor;
EC 1.8.1.9 (thioredoxin reductase) inhibitor;
EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor;
EC 3.5.1.98 (histone deacetylase) inhibitor;
flavouring agent;
food colouring;
geroprotector;
hepatoprotective agent;
immunomodulator;
iron chelator;
ligand;
lipoxygenase inhibitor;
metabolite;
neuroprotective agent;
nutraceutical;
radical scavenger
201920195.0low000010
hypocrellin b2012201212.0low000010
capsaicincapsaicinoidnon-narcotic analgesic;
TRPV1 agonist;
voltage-gated sodium channel blocker
2012201212.0low000010
auraptencoumarins;
monoterpenoid
antihypertensive agent;
antineoplastic agent;
antioxidant;
apoptosis inducer;
dopaminergic agent;
EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor;
gamma-secretase modulator;
gastrointestinal drug;
hepatoprotective agent;
matrix metalloproteinase inhibitor;
neuroprotective agent;
plant metabolite;
PPARalpha agonist;
vulnerary
2012201212.0low000010
chlorogenic acidcinnamate ester;
tannin
food component;
plant metabolite
2012201212.0low000010
fumonisin b2diester;
diol;
fumonisin;
primary amino compound
Aspergillus metabolite;
carcinogenic agent
2012201212.0low000010
lincomycincarbohydrate-containing antibiotic;
L-proline derivative;
monocarboxylic acid amide;
pyrrolidinecarboxamide;
S-glycosyl compound
antimicrobial agent;
bacterial metabolite
2012201212.0low000010
valinomycincyclodepsipeptide;
macrocycle
antimicrobial agent;
antiviral agent;
bacterial metabolite;
potassium ionophore
2012201212.0low000010
orlistatbeta-lactone;
carboxylic ester;
formamides;
L-leucine derivative
anti-obesity agent;
bacterial metabolite;
EC 2.3.1.85 (fatty acid synthase) inhibitor;
EC 3.1.1.3 (triacylglycerol lipase) inhibitor
2012201212.0low000010
quininecinchona alkaloidantimalarial;
muscle relaxant;
non-narcotic analgesic
201920195.0low000010
12-deoxyphorbolphenylacetate-20-acetate2012201212.0low000010
brassinindithiocarbamic ester;
indole phytoalexin
2012201212.0low000010
chaetomellic acid a2012201212.0low000010
3-deoxyvasicine, hydrochloride2012201212.0medium000010
emetine dihydrochloridehydrochlorideanticoronaviral agent;
antimalarial;
antineoplastic agent;
antiprotozoal drug;
antiviral agent;
autophagy inhibitor;
emetic;
protein synthesis inhibitor
2012201212.0low000010
salinomycinpolyketide;
spiroketal
animal growth promotant;
potassium ionophore
2012201212.0low000010
silybin2012201212.0low000010
tolcapone2-nitrophenols;
benzophenones;
catechols
antiparkinson drug;
EC 2.1.1.6 (catechol O-methyltransferase) inhibitor
201920195.0low000010
5,6-dehydrokawain2-pyranones;
aromatic ether
2012201212.0low000010
9,10-dihydrolysergol2012201212.0low000010
geranylgeranic acidalpha,beta-unsaturated monocarboxylic acid;
diterpenoid;
methyl-branched fatty acid;
trienoic fatty acid
2012201212.0low000010
quercetin7-hydroxyflavonol;
pentahydroxyflavone
antibacterial agent;
antineoplastic agent;
antioxidant;
Aurora kinase inhibitor;
chelator;
EC 1.10.99.2 [ribosyldihydronicotinamide dehydrogenase (quinone)] inhibitor;
geroprotector;
phytoestrogen;
plant metabolite;
protein kinase inhibitor;
radical scavenger
201220198.5low000020
dinoprostoneprostaglandins Ehuman metabolite;
mouse metabolite;
oxytocic
2012201212.0low000010
dinoprostmonocarboxylic acid;
prostaglandins Falpha
human metabolite;
mouse metabolite
2012201212.0low000010
biochanin a4'-methoxyisoflavones;
7-hydroxyisoflavones
antineoplastic agent;
EC 3.5.1.99 (fatty acid amide hydrolase) inhibitor;
phytoestrogen;
plant metabolite;
tyrosine kinase inhibitor
2012201212.0low000010
formononetin4'-methoxyisoflavones;
7-hydroxyisoflavones
phytoestrogen;
plant metabolite
2012201212.0low000010
prostaglandin b1prostaglandins Bhuman metabolite2012201212.0low000010
sterigmatocystinsterigmatocystinsmetabolite2012201212.0low000010
vitexinC-glycosyl compound;
trihydroxyflavone
antineoplastic agent;
EC 3.2.1.20 (alpha-glucosidase) inhibitor;
plant metabolite;
platelet aggregation inhibitor
2012201212.0low000010
acacetindihydroxyflavone;
monomethoxyflavone
anticonvulsant;
plant metabolite
2012201212.0low000010
apigenintrihydroxyflavoneantineoplastic agent;
metabolite
2012201212.0low000010
luteolin3'-hydroxyflavonoid;
tetrahydroxyflavone
angiogenesis inhibitor;
anti-inflammatory agent;
antineoplastic agent;
apoptosis inducer;
c-Jun N-terminal kinase inhibitor;
EC 2.3.1.85 (fatty acid synthase) inhibitor;
immunomodulator;
nephroprotective agent;
plant metabolite;
radical scavenger;
vascular endothelial growth factor receptor antagonist
2012201212.0low000010
quercitrinalpha-L-rhamnoside;
monosaccharide derivative;
quercetin O-glycoside;
tetrahydroxyflavone
antileishmanial agent;
antioxidant;
EC 1.1.1.184 [carbonyl reductase (NADPH)] inhibitor;
EC 1.1.1.21 (aldehyde reductase) inhibitor;
EC 1.14.18.1 (tyrosinase) inhibitor;
plant metabolite
201220198.5low000020
scopoletinhydroxycoumarinplant growth regulator;
plant metabolite
2012201212.0low000010
hymecromonehydroxycoumarinantineoplastic agent;
hyaluronic acid synthesis inhibitor
2012201212.0low000010
alprostadilprostaglandins Eanticoagulant;
human metabolite;
platelet aggregation inhibitor;
vasodilator agent
2012201212.0low000010
quercetin 3-o-glucopyranosidebeta-D-glucoside;
monosaccharide derivative;
quercetin O-glucoside;
tetrahydroxyflavone
antineoplastic agent;
antioxidant;
antipruritic drug;
bone density conservation agent;
geroprotector;
histamine antagonist;
osteogenesis regulator;
plant metabolite
2012201212.0low000010
rutindisaccharide derivative;
quercetin O-glucoside;
rutinoside;
tetrahydroxyflavone
antioxidant;
metabolite
2012201212.0low000010
kaempferol7-hydroxyflavonol;
flavonols;
tetrahydroxyflavone
antibacterial agent;
geroprotector;
human blood serum metabolite;
human urinary metabolite;
human xenobiotic metabolite;
plant metabolite
2012201212.0low000010
senecioninelactone;
pyrrolizidine alkaloid;
tertiary alcohol
plant metabolite2012201212.0low000010
genistein7-hydroxyisoflavonesantineoplastic agent;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor;
geroprotector;
human urinary metabolite;
phytoestrogen;
plant metabolite;
tyrosine kinase inhibitor
2012201212.0low000010
amphotericin bantibiotic antifungal drug;
macrolide antibiotic;
polyene antibiotic
antiamoebic agent;
antiprotozoal drug;
bacterial metabolite
2012201212.0low000010
buteinchalcones;
polyphenol
antineoplastic agent;
antioxidant;
EC 1.1.1.21 (aldehyde reductase) inhibitor;
geroprotector;
hypoglycemic agent;
plant metabolite;
radiosensitizing agent;
tyrosine kinase inhibitor
2012201212.0low000010
sulfuretin1-benzofurans2012201212.0low000010
genistin7-hydroxyisoflavones 7-O-beta-D-glucoside2012201212.0low000010
chartreusinbenzochromenone;
glycoside
2012201212.0low000010
caryophyllenebeta-caryophyllenefragrance;
insect attractant;
metabolite;
non-steroidal anti-inflammatory drug
201920195.0low000010
methysticin2-pyranones;
aromatic ether
2012201212.0high000010
yangonin2-pyranones;
aromatic ether
2012201212.0low000010
zearalenonemacrolide;
resorcinols
fungal metabolite;
mycoestrogen
2012201212.0low000010
baicaleintrihydroxyflavoneangiogenesis inhibitor;
anti-inflammatory agent;
antibacterial agent;
anticoronaviral agent;
antifungal agent;
antineoplastic agent;
antioxidant;
apoptosis inducer;
EC 1.13.11.31 (arachidonate 12-lipoxygenase) inhibitor;
EC 1.13.11.33 (arachidonate 15-lipoxygenase) inhibitor;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
EC 3.4.22.69 (SARS coronavirus main proteinase) inhibitor;
EC 4.1.1.17 (ornithine decarboxylase) inhibitor;
ferroptosis inhibitor;
geroprotector;
hormone antagonist;
plant metabolite;
prostaglandin antagonist;
radical scavenger
2012201212.0low000010
chrysin7-hydroxyflavonol;
dihydroxyflavone
anti-inflammatory agent;
antineoplastic agent;
antioxidant;
EC 2.7.11.18 (myosin-light-chain kinase) inhibitor;
hepatoprotective agent;
plant metabolite
2012201212.0low000010
datiscetin7-hydroxyflavonol;
tetrahydroxyflavone
2012201212.0low000010
diosmetin3'-hydroxyflavonoid;
monomethoxyflavone;
trihydroxyflavone
angiogenesis inhibitor;
anti-inflammatory agent;
antineoplastic agent;
antioxidant;
apoptosis inducer;
bone density conservation agent;
cardioprotective agent;
plant metabolite;
tropomyosin-related kinase B receptor agonist;
vasodilator agent
2012201212.0low000010
diosmindihydroxyflavanone;
disaccharide derivative;
glycosyloxyflavone;
monomethoxyflavone;
rutinoside
anti-inflammatory agent;
antioxidant
2012201212.0low000010
fisetin3'-hydroxyflavonoid;
7-hydroxyflavonol;
tetrahydroxyflavone
anti-inflammatory agent;
antioxidant;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor;
geroprotector;
metabolite;
plant metabolite
2012201212.0low000010
galangin7-hydroxyflavonol;
trihydroxyflavone
antimicrobial agent;
EC 3.1.1.3 (triacylglycerol lipase) inhibitor;
plant metabolite
2012201212.0low000010
mangostinaromatic ether;
phenols;
xanthones
antimicrobial agent;
antineoplastic agent;
antioxidant;
plant metabolite
201920195.0low000010
3-methylquercetin7-hydroxyflavonol;
monomethoxyflavone;
tetrahydroxyflavone
anticoagulant;
EC 1.14.18.1 (tyrosinase) inhibitor;
metabolite
2012201212.0low000010
morin7-hydroxyflavonol;
pentahydroxyflavone
angiogenesis modulating agent;
anti-inflammatory agent;
antibacterial agent;
antihypertensive agent;
antineoplastic agent;
antioxidant;
EC 5.99.1.2 (DNA topoisomerase) inhibitor;
hepatoprotective agent;
metabolite;
neuroprotective agent
2012201212.0low000010
myricetin7-hydroxyflavonol;
hexahydroxyflavone
antineoplastic agent;
antioxidant;
cyclooxygenase 1 inhibitor;
food component;
geroprotector;
hypoglycemic agent;
plant metabolite
2012201212.0low000010
rhamnetinmonomethoxyflavone;
tetrahydroxyflavone
anti-inflammatory agent;
antioxidant;
metabolite
2012201212.0low000010
robinetin7-hydroxyflavonol;
pentahydroxyflavone
plant metabolite2012201212.0low000010
tamarixetin7-hydroxyflavonol;
monomethoxyflavone;
tetrahydroxyflavone
antioxidant;
metabolite
2012201212.0low000010
wogonindihydroxyflavone;
monomethoxyflavone
angiogenesis inhibitor;
antineoplastic agent;
cyclooxygenase 2 inhibitor;
plant metabolite
2012201212.0low000010
coumestrolcoumestans;
delta-lactone;
polyphenol
anti-inflammatory agent;
antioxidant;
plant metabolite
2012201212.0low000010
daidzein7-hydroxyisoflavonesantineoplastic agent;
EC 2.7.7.7 (DNA-directed DNA polymerase) inhibitor;
EC 3.2.1.20 (alpha-glucosidase) inhibitor;
phytoestrogen;
plant metabolite
2012201212.0low000010
caffeic acid phenethyl esteralkyl caffeate esteranti-inflammatory agent;
antibacterial agent;
antineoplastic agent;
antioxidant;
antiviral agent;
immunomodulator;
metabolite;
neuroprotective agent
2012201212.0low000010
rosmarinic acidrosmarinic acidgeroprotector;
plant metabolite
2012201212.0low000010
wedelolactonearomatic ether;
coumestans;
delta-lactone;
polyphenol
antineoplastic agent;
apoptosis inducer;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor;
hepatoprotective agent;
metabolite
2012201212.0low000010
rottlerinaromatic ketone;
benzenetriol;
chromenol;
enone;
methyl ketone
anti-allergic agent;
antihypertensive agent;
antineoplastic agent;
apoptosis inducer;
K-ATP channel agonist;
metabolite
2012201212.0low000010
ellagic acidcatechols;
cyclic ketone;
lactone;
organic heterotetracyclic compound;
polyphenol
antioxidant;
EC 1.14.18.1 (tyrosinase) inhibitor;
EC 2.3.1.5 (arylamine N-acetyltransferase) inhibitor;
EC 2.4.1.1 (glycogen phosphorylase) inhibitor;
EC 2.5.1.18 (glutathione transferase) inhibitor;
EC 2.7.1.127 (inositol-trisphosphate 3-kinase) inhibitor;
EC 2.7.1.151 (inositol-polyphosphate multikinase) inhibitor;
EC 2.7.4.6 (nucleoside-diphosphate kinase) inhibitor;
EC 2.7.7.7 (DNA-directed DNA polymerase) inhibitor;
EC 5.99.1.2 (DNA topoisomerase) inhibitor;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor;
food additive;
fungal metabolite;
geroprotector;
plant metabolite;
skin lightening agent
2012201212.0low000010
7-hydroxyflavonehydroxyflavonoid2012201212.0low000010
prostaglandin a1prostaglandins A2012201212.0low000010
ceruleninepoxide;
monocarboxylic acid amide
antifungal agent;
antiinfective agent;
antilipemic drug;
antimetabolite;
antimicrobial agent;
fatty acid synthesis inhibitor
2012201212.0low000010
rhoifolindihydroxyflavone;
glycosyloxyflavone;
neohesperidoside
metabolite2012201212.0low000010
vitexin rhamnosideC-glycosyl compound;
disaccharide derivative;
trihydroxyflavone
plant metabolite2012201212.0medium000010
domoic acidL-proline derivative;
non-proteinogenic L-alpha-amino acid;
pyrrolidinecarboxylic acid;
tricarboxylic acid
algal metabolite;
hapten;
marine metabolite;
neuromuscular agent;
neurotoxin
2012201212.0low000010
isotretinoinretinoic acidantineoplastic agent;
keratolytic drug;
teratogenic agent
2012201212.0low000010
cyclosporinehomodetic cyclic peptideanti-asthmatic drug;
anticoronaviral agent;
antifungal agent;
antirheumatic drug;
carcinogenic agent;
dermatologic drug;
EC 3.1.3.16 (phosphoprotein phosphatase) inhibitor;
geroprotector;
immunosuppressive agent;
metabolite
2012201212.0low000010
natamycinantibiotic antifungal drug;
dicarboxylic acid monoester;
epoxide;
macrolide antibiotic;
monosaccharide derivative;
polyene antibiotic
antifungal agrochemical;
antimicrobial food preservative;
apoptosis inducer;
bacterial metabolite;
ophthalmology drug
2012201212.0low000010
sirolimusantibiotic antifungal drug;
cyclic acetal;
cyclic ketone;
ether;
macrolide lactam;
organic heterotricyclic compound;
secondary alcohol
antibacterial drug;
anticoronaviral agent;
antineoplastic agent;
bacterial metabolite;
geroprotector;
immunosuppressive agent;
mTOR inhibitor
2012201212.0low000010
brefeldin amacrolide antibioticPenicillium metabolite201220198.5low000020
peridinin201920195.0low000010
cytochalasin bcytochalasin;
lactam;
lactone;
organic heterotricyclic compound
actin polymerisation inhibitor;
metabolite;
mycotoxin;
platelet aggregation inhibitor
2012201212.0low000010
vinorelbineacetate ester;
methyl ester;
organic heteropentacyclic compound;
organic heterotetracyclic compound;
ring assembly;
vinca alkaloid
antineoplastic agent;
photosensitizing agent
2012201212.0low000010
bisdemethoxycurcuminbeta-diketone;
diarylheptanoid;
enone;
polyphenol
EC 3.2.1.1 (alpha-amylase) inhibitor;
metabolite
2012201212.0low000010
andrographolidecarbobicyclic compound;
gamma-lactone;
labdane diterpenoid;
primary alcohol;
secondary alcohol
anti-HIV agent;
anti-inflammatory drug;
antineoplastic agent;
metabolite
201220198.5low000020
isorhamnetin 3-o-glucosidebeta-D-glucoside;
glycosyloxyflavone;
monomethoxyflavone;
monosaccharide derivative;
trihydroxyflavone
metabolite2012201212.0low000010
su 11248monocarboxylic acid amide;
pyrroles
angiogenesis inhibitor;
antineoplastic agent;
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor;
immunomodulator;
neuroprotective agent;
vascular endothelial growth factor receptor antagonist
201920195.0low000010
6,7-dihydroxyflavone2012201212.0low000010
flavokawain achalcones2012201212.0low000010
flavokawain bchalcones;
dimethoxybenzene;
phenols
anti-inflammatory agent;
antileishmanial agent;
antineoplastic agent;
apoptosis inducer;
metabolite
2012201212.0low000010
kavainracemateglycine receptor antagonist2012201212.0low000010
abscisic acid, (+,-)-isomerabscisic acidsabscisic acid receptor agonist2012201212.0medium000010
veratrinealkaloid2012201212.0low000010
vinblastine sulfate2012201212.0low000010
catharanthinealkaloid ester;
bridged compound;
methyl ester;
monoterpenoid indole alkaloid;
organic heteropentacyclic compound;
tertiary amino compound
2012201212.0low000010
cytochalasin ecytochalasan alkaloidmetabolite2012201212.0low000010
cytochalasin d2012201212.0medium000010
sinomeninemorphinane alkaloid2012201212.0low000010
ecdysterone14alpha-hydroxy steroid;
20-hydroxy steroid;
22-hydroxy steroid;
25-hydroxy steroid;
2beta-hydroxy steroid;
3beta-sterol;
ecdysteroid;
phytoecdysteroid
animal metabolite;
plant metabolite
2012201212.0low000010
bleomycinbleomycinantineoplastic agent;
metabolite
2012201212.0low000010
bakuchiol2012201212.0low000010
zerumbonecyclic ketone;
sesquiterpenoid
anti-inflammatory agent;
glioma-associated oncogene inhibitor;
plant metabolite
2012201212.0low000010
solanesolnonaprenol;
primary alcohol
plant metabolite2012201212.0low000010
(1S,15S,17R,18R,19S,20S)-6,18-dimethoxy-17-[oxo-(3,4,5-trimethoxyphenyl)methoxy]-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylic acid methyl esteryohimban alkaloid2012201212.0high000010
n-caproylsphingosineN-acylsphingosine2012201212.0low000010
monordencyclic ketone;
enone;
epoxide;
macrolide antibiotic;
monochlorobenzenes;
phenols
antifungal agent;
metabolite;
tyrosine kinase inhibitor
2012201212.0low000010
ginkgolide b2012201212.0low000010
homatropine hydrobromide, (endo-(+-)-isomer)2012201212.0low000010
hydrocotarnine hydrobromide2012201212.0low000010
salsolinol hydrobromide2012201212.0medium000010
lasalocid sodiumbenzoates;
organic sodium salt
coccidiostat;
ionophore
2012201212.0low000010
sclerotiorinazaphilone2012201212.0low000010
himbacinegamma-lactone;
organic heterotricyclic compound;
piperidine alkaloid
muscarinic antagonist2012201212.0low000010
ebelactone b2012201212.0low000010
3-o-methylbuteinchalcones2012201212.0medium000010
thermozymocidinalpha-amino fatty acid;
hydroxy monocarboxylic acid;
non-proteinogenic alpha-amino acid;
sphingoid
antifungal agent;
antimicrobial agent;
antineoplastic agent;
apoptosis inducer;
EC 2.3.1.50 (serine C-palmitoyltransferase) inhibitor;
fungal metabolite;
immunosuppressive agent
2012201212.0low000010
mareinflavonoids;
glycoside
2012201212.0low000010
hydroxyachillingamma-lactone2012201212.0medium000010
butylscopolammonium bromide2012201212.0low000010
fumagillinantibiotic antifungal drug;
carboxylic ester;
dicarboxylic acid monoester;
meroterpenoid;
organooxygen heterocyclic antibiotic;
spiro-epoxide
angiogenesis inhibitor;
antibacterial drug;
antimicrobial agent;
antiprotozoal drug;
fungal metabolite;
methionine aminopeptidase 2 inhibitor
2012201212.0low000010
artesunateartemisinin derivative;
cyclic acetal;
dicarboxylic acid monoester;
hemisuccinate;
semisynthetic derivative;
sesquiterpenoid
antimalarial;
antineoplastic agent;
ferroptosis inducer
2012201212.0low000010
anisodamine2012201212.0medium000010
cyclo(leucyl-prolyl)dipeptide;
homodetic cyclic peptide;
pyrrolopyrazine
bacterial metabolite;
marine metabolite
201920195.0low000010
bufalin14beta-hydroxy steroid;
3beta-hydroxy steroid
animal metabolite;
anti-inflammatory agent;
antineoplastic agent;
cardiotonic drug
2012201212.0low000010
alpha-solanineglycoalkaloid;
organic heterohexacyclic compound;
steroid saponin;
trisaccharide derivative
antineoplastic agent;
apoptosis inducer;
phytotoxin;
plant metabolite
2012201212.0medium000010
apigenin-7-o-rutinoside2012201212.0medium000010
gambogic acidpyranoxanthonesmetabolite2012201212.0low000010
bn 520202012201212.0low000010
osu 03012antibiotic antifungal drug;
aromatic amide;
glycine derivative;
organofluorine compound;
phenanthrenes;
pyrazoles
antineoplastic agent;
apoptosis inducer;
EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor
201920195.0low000010
carmineC-glycosyl compound;
monocarboxylic acid;
tetrahydroxyanthraquinone
animal metabolite;
histological dye
2012201212.0low000010
bavachininflavanones2012201212.0low000010
grayanotoxin iii2012201212.0low000010
Dihydrotanshinone Iabietane diterpenoidanticoronaviral agent2012201212.0low000010
lactimidomycinmacrolide201920195.0low000010
calcimycinbenzoxazole2012201212.0low000010
cinobufaginsteroid lactone2012201212.0low000010
atropine sulfate2012201212.0low000010
cannogenin thevetosidecardenolide glycoside2012201212.0low000010
eriodictyol 7-O-beta-D-glucopyranosidebeta-D-glucoside;
flavanone glycoside;
monosaccharide derivative;
trihydroxyflavanone
plant metabolite;
radical scavenger
2012201212.0medium000010
hypocrellin a2012201212.0low000010
dihydrorobinetin2012201212.0high000010
monensin2012201212.0medium000010
sofosbuvirisopropyl ester;
L-alanyl ester;
nucleotide conjugate;
organofluorine compound;
phosphoramidate ester
antiviral drug;
hepatitis C protease inhibitor;
prodrug
201920195.0low000010
tatanan a201920195.0medium000010
minocycline2012201212.0low000010
dicumarolhydroxycoumarinanticoagulant;
EC 1.6.5.2 [NAD(P)H dehydrogenase (quinone)] inhibitor;
Hsp90 inhibitor;
vitamin K antagonist
2012201212.0low000010
citrinin2012201212.0low000010
vulpinic acidbutenolide2012201212.0low000010
ajmaline2012201212.0medium000010
rifampincyclic ketal;
hydrazone;
N-iminopiperazine;
N-methylpiperazine;
rifamycins;
semisynthetic derivative;
zwitterion
angiogenesis inhibitor;
antiamoebic agent;
antineoplastic agent;
antitubercular agent;
DNA synthesis inhibitor;
EC 2.7.7.6 (RNA polymerase) inhibitor;
Escherichia coli metabolite;
geroprotector;
leprostatic drug;
neuroprotective agent;
pregnane X receptor agonist;
protein synthesis inhibitor
2012201212.0low000010
alpha-cyclopiazonic acidalpha-cyclopiazonic acids2012201212.0low000010
SubstanceStudiesClassesRolesFirst YearLast YearAverage AgeRelationship StrengthTrialspre-19901990's2000's2010'spost-2020
methanolalkyl alcohol;
one-carbon compound;
primary alcohol;
volatile organic compound
amphiprotic solvent;
Escherichia coli metabolite;
fuel;
human metabolite;
mouse metabolite;
Mycoplasma genitalium metabolite
2011201113.0low000010
caffeinepurine alkaloid;
trimethylxanthine
adenosine A2A receptor antagonist;
adenosine receptor antagonist;
adjuvant;
central nervous system stimulant;
diuretic;
EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor;
EC 3.1.4.* (phosphoric diester hydrolase) inhibitor;
environmental contaminant;
food additive;
fungal metabolite;
geroprotector;
human blood serum metabolite;
mouse metabolite;
mutagen;
plant metabolite;
psychotropic drug;
ryanodine receptor agonist;
xenobiotic
1992199232.0low001000
hexamethoniumquaternary ammonium salt1991199133.0low001000
nifedipineC-nitro compound;
dihydropyridine;
methyl ester
calcium channel blocker;
human metabolite;
tocolytic agent;
vasodilator agent
1991199133.0low001000
potassium chlorideinorganic chloride;
inorganic potassium salt;
potassium salt
fertilizer2011201113.0low000010
procainebenzoate ester;
substituted aniline;
tertiary amino compound
central nervous system depressant;
drug allergen;
local anaesthetic;
peripheral nervous system drug
1983198341.0low010000
dimethylphenylpiperazinium iodideN-arylpiperazine;
organic iodide salt;
piperazinium salt;
quaternary ammonium salt
nicotinic acetylcholine receptor agonist1983198341.0low010000
(4-(m-chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium chloride1983198341.0low010000
phenylephrinephenols;
phenylethanolamines;
secondary amino compound
alpha-adrenergic agonist;
cardiotonic drug;
mydriatic agent;
nasal decongestant;
protective agent;
sympathomimetic agent;
vasoconstrictor agent
2011201113.0low000010
tryptophanerythrose 4-phosphate/phosphoenolpyruvate family amino acid;
L-alpha-amino acid zwitterion;
L-alpha-amino acid;
proteinogenic amino acid;
tryptophan zwitterion;
tryptophan
antidepressant;
Escherichia coli metabolite;
human metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
plant metabolite;
Saccharomyces cerevisiae metabolite
2009200915.0low000100
yohimbinemethyl 17-hydroxy-20xi-yohimban-16-carboxylatealpha-adrenergic antagonist;
dopamine receptor D2 antagonist;
serotonergic antagonist
1990200128.5low001100
oleanolic acidhydroxy monocarboxylic acid;
pentacyclic triterpenoid
plant metabolite201520159.0low000010
3-hydroxyflavoneflavonols;
monohydroxyflavone
2004200619.0low000200
2-piperidonedelta-lactam;
piperidones
EC 1.2.1.88 (L-glutamate gamma-semialdehyde dehydrogenase) inhibitor2009200915.0low000100
camptothecindelta-lactone;
pyranoindolizinoquinoline;
quinoline alkaloid;
tertiary alcohol
antineoplastic agent;
EC 5.99.1.2 (DNA topoisomerase) inhibitor;
genotoxin;
plant metabolite
201520159.0low000010
phosphinemononuclear parent hydride;
phosphanes;
phosphine
carcinogenic agent;
fumigant insecticide
2012201212.0low000010
glutamic acidglutamic acid;
glutamine family amino acid;
L-alpha-amino acid;
proteinogenic amino acid
Escherichia coli metabolite;
ferroptosis inducer;
micronutrient;
mouse metabolite;
neurotransmitter;
nutraceutical
1997201418.5low001010
irinotecancarbamate ester;
delta-lactone;
N-acylpiperidine;
pyranoindolizinoquinoline;
ring assembly;
tertiary alcohol;
tertiary amino compound
antineoplastic agent;
apoptosis inducer;
EC 5.99.1.2 (DNA topoisomerase) inhibitor;
prodrug
201520159.0low000010
nicotine3-(1-methylpyrrolidin-2-yl)pyridineanxiolytic drug;
biomarker;
immunomodulator;
mitogen;
neurotoxin;
nicotinic acetylcholine receptor agonist;
peripheral nervous system drug;
phytogenic insecticide;
plant metabolite;
psychotropic drug;
teratogenic agent;
xenobiotic
1991199133.0low001000
mitraphyllineindolizines202120213.0low000001
saikosaponin d201520159.0low000010
dihydrocorynantheol2009200915.0medium000100
yc 170anilide1991199133.0low001000
atropine1983198341.0low010000
2-oxindolegamma-lactam;
indolinone
2011201113.0low000010
strychninemonoterpenoid indole alkaloid;
organic heteroheptacyclic compound
avicide;
cholinergic antagonist;
glycine receptor antagonist;
neurotransmitter agent;
rodenticide
1997199727.0low001000
glycosides2006200618.0low000100
rhyncophylline201420159.5low000020
mitragyninemonoterpenoid indole alkaloid202120213.0low000001
paynantheine202120213.0medium000001
quercetin7-hydroxyflavonol;
pentahydroxyflavone
antibacterial agent;
antineoplastic agent;
antioxidant;
Aurora kinase inhibitor;
chelator;
EC 1.10.99.2 [ribosyldihydronicotinamide dehydrogenase (quinone)] inhibitor;
geroprotector;
phytoestrogen;
plant metabolite;
protein kinase inhibitor;
radical scavenger
2004200420.0low000100
dinoprostoneprostaglandins Ehuman metabolite;
mouse metabolite;
oxytocic
2013201311.0low000010
rutindisaccharide derivative;
quercetin O-glucoside;
rutinoside;
tetrahydroxyflavone
antioxidant;
metabolite
2000200621.0low001100
3-methylquercetin7-hydroxyflavonol;
monomethoxyflavone;
tetrahydroxyflavone
anticoagulant;
EC 1.14.18.1 (tyrosinase) inhibitor;
metabolite
2004200420.0low000100
astragalinbeta-D-glucoside;
kaempferol O-glucoside;
monosaccharide derivative;
trihydroxyflavone
plant metabolite;
trypanocidal drug
2000200024.0low001000
raubasineyohimban alkaloid202120213.0low000001
beta-escin201520159.0low000010
tryptophanol2009200915.0low000100
corynoxine bindolizinesmetabolite202120213.0medium000001
corynoxineindolizinesmetabolite202120213.0medium000001
calcimycinbenzoxazole1991199133.0low001000
hirsuteine1990202017.2high002130
mitragynine202120213.0medium000001
cytochrome c-t201820186.0low000020
picrotoxin1997199727.0low001000
7-hydroxymitragyninealkaloid202120213.0low000001
ConditionIndicatedStudiesFirst YearLast YearAverage AgeRelationship StrengthTrialspre-19901990's2000's2010'spost-2020
Absence Seizure01997199727.0low001000
Adrenal Cancer01991199133.0low001000
Alloxan Diabetes0202220222.0low000001
Anesthesia01989198935.0low010000
Blood Pressure, High0201520159.0low000010
Breast Cancer0201420188.3low000030
Breast Neoplasms0201420188.3low000030
Cancer of Lung0201820186.0low000010
Cardiac Hypertrophy0202220222.0low000001
Cardiomegaly0202220222.0low000001
Cardiovascular Stroke0202320231.0low000001
Diabetes Mellitus, Adult-Onset0202220222.0low000001
Diabetes Mellitus, Type 20202220222.0low000001
Disease Models, Animal0201520159.0low000010
Experimental Neoplasms02014201410.0low000010
Fatty Liver0202220222.0low000001
Hypertension0201520159.0low000010
Inflammation02013201311.0low000010
Injury, Myocardial Reperfusion0202320231.0low000001
Innate Inflammatory Response02013201311.0low000010
Insulin Resistance0202220222.0low000001
Insulin Sensitivity0202220222.0low000001
Liver Steatosis0202220222.0low000001
Lung Neoplasms0201820186.0low000010
Metastase02014201410.0low000010
Muscle Contraction01983199236.5low011000
Myocardial Infarction0202320231.0low000001
Neoplasm Metastasis02014201410.0low000010
Pheochromocytoma01991199133.0low001000
Pheochromocytoma, Extra-Adrenal01991199133.0low001000
Seizures01997199727.0low001000
Sensitivity and Specificity0201420207.0low000020
Thrombocytopenia0202220222.0low000001
Thrombopenia0202220222.0low000001

Safety/Toxicity (1)

ArticleYear
Hirsutine, an indole alkaloid of Uncaria rhynchophylla, inhibits inflammation-mediated neurotoxicity and microglial activation.
Molecular medicine reports, , Volume: 7, Issue:1
2013

Pharmacokinetics (1)

ArticleYear
Bioanalytical method development and validation of corynantheidine, a kratom alkaloid, using UPLC-MS/MS, and its application to preclinical pharmacokinetic studies.
Journal of pharmaceutical and biomedical analysis, , Feb-20, Volume: 180
2020

Bioavailability (1)

ArticleYear
Bioanalytical method development and validation of corynantheidine, a kratom alkaloid, using UPLC-MS/MS, and its application to preclinical pharmacokinetic studies.
Journal of pharmaceutical and biomedical analysis, , Feb-20, Volume: 180
2020

Dosage (1)

ArticleYear
Ca2+ channel blocking effects of hirsutine, an indole alkaloid from Uncaria genus, in the isolated rat aorta.
Planta medica, , Volume: 57, Issue:5
1991